These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 13659226)

  • 1. [Experiences with peroral therapy of diabetes; carbamideurea and sulfonylurea].
    BRKIC D; POPOVIC S; SPASOJEVIC L; MICIC J; BABIC D; RADOSAVLJEVIC M
    Srp Arh Celok Lek; 1959 Jan; 87(1):31-43. PubMed ID: 13659226
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with sulfonylurea therapy in tuberculosis of diabetic patients].
    MARTON S; BANYASZ T; MEDVECZKY E
    Orv Hetil; 1958 Jun; 99(26):878-84. PubMed ID: 13566802
    [No Abstract]   [Full Text] [Related]  

  • 3. The problem of failures in peroral therapy of diabetes.
    STRAUZENBERG SE; HALLER H; MEYER H
    Munch Med Wochenschr; 1958 Oct; 100(40):1535-40. PubMed ID: 13600289
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on peroral therapy for diabetes.
    IKKALA E; KAIPAINEN WJ
    Ann Med Intern Fenn; 1958; 47(2):63-73. PubMed ID: 13595360
    [No Abstract]   [Full Text] [Related]  

  • 5. [So-called late failures of peroral diabetes therapy].
    HEINSEN HA
    Endokrinologie; 1958 Jul; 36(3-4):229-36. PubMed ID: 13586234
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with a several-year sulfonylurea therapy in the ambulant therapy of diabetes].
    HAMBSCH K; OTTO W
    Dtsch Gesundheitsw; 1961 Aug; 16():1474-9. PubMed ID: 13710969
    [No Abstract]   [Full Text] [Related]  

  • 7. [First experiences in oral therapy of diabetes with hypoglycemic sulfonamides].
    KECOVA H
    Cas Lek Cesk; 1958 Mar; 97(10):327-33. PubMed ID: 13537006
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experiences with the sulfonylurea compounds.
    DUNCAN GG; LEE CT; YOUNG JK
    Ann N Y Acad Sci; 1957 Jul; 71(1):233-8. PubMed ID: 13459219
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes.
    Charbonnel B
    Int J Clin Pract Suppl; 2007 Jun; (153):1-2. PubMed ID: 17594387
    [No Abstract]   [Full Text] [Related]  

  • 10. [Peroral treatment of diabetes with tolbutamide].
    AARSETH S
    Tidsskr Nor Laegeforen; 1957 Dec; 77(24):1135-9. PubMed ID: 13529921
    [No Abstract]   [Full Text] [Related]  

  • 11. Practical review of oral antihyperglycemic agents for type 2 diabetes mellitus.
    Koski RR
    Diabetes Educ; 2006; 32(6):869-76. PubMed ID: 17102154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [First experiences with biguanid compounds in the therapy of diabetes mellitus].
    OTTO H
    Medizinische; 1958 Jul; 3(27-28):1080-2. PubMed ID: 13565242
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience with the treatment of diabetes with sulfonylurea (D 860)].
    BEROVIC R; DEVECERSKI M
    Srp Arh Celok Lek; 1958 Feb; 86(2):157-69. PubMed ID: 13569016
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experience with sulfonylurea compounds in diabetes.
    MARBLE A; CAMERINI-DAVALOS R
    Ann N Y Acad Sci; 1957 Jul; 71(1):239-48. PubMed ID: 13459220
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulfonylurea-responsive diabetes in childhood.
    Landau Z; Wainstein J; Hanukoglu A; Tuval M; Lavie J; Glaser B
    J Pediatr; 2007 May; 150(5):553-5. PubMed ID: 17452235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of intensive glucose control in type 2 diabetes.
    Petrie JR
    N Engl J Med; 2009 Jan; 360(4):416-7; author reply 418. PubMed ID: 19172672
    [No Abstract]   [Full Text] [Related]  

  • 17. Follow-up of intensive glucose control in type 2 diabetes.
    Mühlhauser I
    N Engl J Med; 2009 Jan; 360(4):417; author reply 418. PubMed ID: 19172674
    [No Abstract]   [Full Text] [Related]  

  • 18. [Peroral treatment of diabetes].
    IVERSEN M
    Manedsskr Prakt Laegegern; 1958 May; 36(5):193-7. PubMed ID: 13551226
    [No Abstract]   [Full Text] [Related]  

  • 19. Treating type 2 diabetes: targeting the many causative factors.
    Sutherland JE; Hoehns JD
    J Fam Pract; 2004 May; 53(5):376-88. PubMed ID: 15125823
    [No Abstract]   [Full Text] [Related]  

  • 20. New oral hypoglycemic drugs in diabetes; clinical experiences.
    RADDING RS
    Tex State J Med; 1959 Feb; 55(2):110-4. PubMed ID: 13635619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.